IL132121A0 - Leishmania vaccine - Google Patents

Leishmania vaccine

Info

Publication number
IL132121A0
IL132121A0 IL13212198A IL13212198A IL132121A0 IL 132121 A0 IL132121 A0 IL 132121A0 IL 13212198 A IL13212198 A IL 13212198A IL 13212198 A IL13212198 A IL 13212198A IL 132121 A0 IL132121 A0 IL 132121A0
Authority
IL
Israel
Prior art keywords
leishmania vaccine
leishmania
vaccine
Prior art date
Application number
IL13212198A
Other languages
English (en)
Original Assignee
Univ Glasgow
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Glasgow filed Critical Univ Glasgow
Publication of IL132121A0 publication Critical patent/IL132121A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/008—Leishmania antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/947—Microorganisms using protozoa

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL13212198A 1997-04-04 1998-04-03 Leishmania vaccine IL132121A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9706930.6A GB9706930D0 (en) 1997-04-04 1997-04-04 Leishmania vaccine
PCT/GB1998/000994 WO1998044943A1 (en) 1997-04-04 1998-04-03 Leishmania vaccine

Publications (1)

Publication Number Publication Date
IL132121A0 true IL132121A0 (en) 2001-03-19

Family

ID=10810338

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13212198A IL132121A0 (en) 1997-04-04 1998-04-03 Leishmania vaccine

Country Status (7)

Country Link
US (1) US6890542B2 (pt)
EP (1) EP0973545A1 (pt)
AP (1) AP9901666A0 (pt)
BR (1) BR9807927A (pt)
GB (1) GB9706930D0 (pt)
IL (1) IL132121A0 (pt)
WO (1) WO1998044943A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9706930D0 (en) 1997-04-04 1997-05-21 Univ Glasgow Leishmania vaccine
GB9807293D0 (en) * 1998-04-03 1998-06-03 Univ Glasgow Leishmania cysteine proteinases
US9023366B2 (en) * 2003-07-01 2015-05-05 The Royal Veterinary College Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
FR2861740B1 (fr) 2003-10-29 2005-12-16 Inst Rech Developpement Ird Souches de protozoaire de virulence attenuee et leur utilisation
WO2008039171A2 (en) 2005-08-08 2008-04-03 Oregon Health & Science University Inactivating pathogens with hydrogen peroxide for vaccine production
ES2352780B2 (es) 2009-06-04 2011-09-15 Laboratorios Ovejero S.A. Lipopolisacárido de ochrobactrum intermedium contra la sepsis.
EP2633855A1 (en) 2012-03-01 2013-09-04 Veterinärmedizinische Universität Wien Protease inhibitors for treating Trichomonas gallinae infections
US10053695B2 (en) * 2014-03-26 2018-08-21 The Penn State Research Foundation Modulation of CCR10 signals for treatment of skin and intestinal inflammatory diseases and infection
WO2017197034A1 (en) 2016-05-10 2017-11-16 Najit Technologies, Inc. Inorganic polyatomic oxyanions for protecting against antigenic damage during pathogen inactivation for vaccine production
US11219677B2 (en) * 2017-05-05 2022-01-11 Rosalind Franklin University Of Medicine And Science Immunotherapy of canine leishmaniasis
US20200376100A1 (en) * 2019-05-31 2020-12-03 Rosalind Franklin Univ. of Medicine and Science Immunotherapy of solid tumors by vaccination with transgenic leishmania expressing cancer vaccines and with recombinant vaccines with leishmania as adjuvants

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US576292A (en) * 1897-02-02 Baby-carrier
US5726292A (en) * 1987-06-23 1998-03-10 Lowell; George H. Immuno-potentiating systems for preparation of immunogenic materials
US5955333A (en) * 1991-08-13 1999-09-21 President & Fellows Of Harvard College Double targeted gene replacement in unicellular diploid organisms
ATE236252T1 (de) * 1993-09-03 2003-04-15 Univ Mcgill Differentiell exprimierte leishmania gene und proteinen
GB9403819D0 (en) * 1994-02-28 1994-04-20 Univ Leeds Control of parasites
US5965143A (en) * 1996-03-12 1999-10-12 Fasel; Nicolas Joseph Immunity to trypanosomatids species
US6162638A (en) * 1996-05-06 2000-12-19 Universite Laval Attenuated strains of leishmania and uses thereof
US6020144A (en) * 1996-09-12 2000-02-01 Symbiontics, Inc. Sustained delivery device comprising a Leishmania protozoa and methods of making and using the same
US6331304B1 (en) * 1996-09-13 2001-12-18 Universite Laval Macrophage-infecting parasites expressing a granulocyte macrophage colony stimulating factor
GB9706930D0 (en) 1997-04-04 1997-05-21 Univ Glasgow Leishmania vaccine
GB9807293D0 (en) 1998-04-03 1998-06-03 Univ Glasgow Leishmania cysteine proteinases

Also Published As

Publication number Publication date
EP0973545A1 (en) 2000-01-26
US6890542B2 (en) 2005-05-10
BR9807927A (pt) 2000-02-22
WO1998044943A1 (en) 1998-10-15
AP9901666A0 (en) 1999-12-31
GB9706930D0 (en) 1997-05-21
US20040005326A1 (en) 2004-01-08

Similar Documents

Publication Publication Date Title
GB9712347D0 (en) Vaccine
GB9718901D0 (en) Vaccine
PL341698A1 (en) Vaccine
GB9711990D0 (en) Vaccine
GB9726555D0 (en) Vaccine
GB9720585D0 (en) Vaccine
HK1010833A1 (en) Influenza vaccine
GB9620795D0 (en) Vaccines
EP1083926A4 (en) VACCINE
EP0958373A4 (en) Vaccines.
IL132121A0 (en) Leishmania vaccine
ZA9711565B (en) Vaccine
ZA982763B (en) Vaccines
GB9625968D0 (en) Vaccine
GB9814470D0 (en) Parasite vaccine
GB9717423D0 (en) Vaccine
GB9720982D0 (en) Vaccine
GB9718902D0 (en) Vaccine
GB9702920D0 (en) Vaccines
GB9609252D0 (en) Vaccines
PL322663A1 (en) Dispergating preparation
GB9725241D0 (en) Hiv vaccine
GB9703202D0 (en) HIV vaccine
GB9625967D0 (en) Vaccine
GB9625966D0 (en) Vaccine